Public Citizen Calls on FDA to Ban Antibiotic Tequin
Antibiotic Is Linked to Increased Risk of Blood Sugar Abnormalities, Responsible for 20 Deaths and 159 Hospitalizations

US group seeks ban on discontinued Bristol drug

Antibiotic pulled from Canadian and U.S. markets

Tequin's Serious Injuries - Bristol-Myers Feigns

Antibiotic Tequin taken off market

Troublesome Tequin coming off market

FDA Asked to Ban Antibiotic Tequin

ANTIBIOTIC TEQUIN TO DISAPPEAR SOON

Company Pulls Antibiotic Tequin Off the Market

Bristol-Myers to stop sale, manufacture of antibiotic Tequin

PUBLIC COMMUNICATION Health Canada Endorsed Important Safety Information on Tequin* (gatifloxacin) December 19, 2005

FDA, Bristol-Myers warn on antibiotic Tequin By Jennifer Corbett Dooren Last Update: 1:06 PM ET Feb 16, 2006

Diabetics warned against using antibiotic drug Tequin Pharmaceutical News Published: Thursday, 16-Feb-2006

Stronger warnings for antibiotic Tequin ROCKVILLE, Md., Feb. 16 (UPI) -- The Food and Drug Administration said Monday Bristol-Myers Squibb has bolstered its warnings for Tequin(gatifloxacin).

Canadian Adverse Reaction Newsletter Volume 13, Number 3, July 2003 Gatifloxacin (Tequin™): hypoglycemia and hyperglycemia

UPDATE 2-Bristol-Myers warns diabetics about Tequin-FDA
Thu Feb 16, 2006 2:16 PM ET WASHINGTON, Feb 16 (Reuters)

Stronger Warnings for Tequin